NO20034528D0 - 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser - Google Patents

3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser

Info

Publication number
NO20034528D0
NO20034528D0 NO20034528A NO20034528A NO20034528D0 NO 20034528 D0 NO20034528 D0 NO 20034528D0 NO 20034528 A NO20034528 A NO 20034528A NO 20034528 A NO20034528 A NO 20034528A NO 20034528 D0 NO20034528 D0 NO 20034528D0
Authority
NO
Norway
Prior art keywords
diazabicyclo
formulations
antiarrhythmic compounds
antiarrhythmic
compounds
Prior art date
Application number
NO20034528A
Other languages
English (en)
Other versions
NO20034528L (no
Inventor
Hans Carlsson
Anette Larsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101325A external-priority patent/SE0101325D0/xx
Priority claimed from SE0101326A external-priority patent/SE0101326D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20034528D0 publication Critical patent/NO20034528D0/no
Publication of NO20034528L publication Critical patent/NO20034528L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20034528A 2001-04-12 2003-10-09 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser NO20034528L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0101325A SE0101325D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
SE0101326A SE0101326D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
PCT/SE2002/000724 WO2002083687A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds

Publications (2)

Publication Number Publication Date
NO20034528D0 true NO20034528D0 (no) 2003-10-09
NO20034528L NO20034528L (no) 2003-12-08

Family

ID=26655442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034528A NO20034528L (no) 2001-04-12 2003-10-09 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser

Country Status (23)

Country Link
US (1) US20040132798A1 (no)
EP (1) EP1389211A1 (no)
JP (1) JP2004525969A (no)
KR (1) KR20040005917A (no)
CN (1) CN1279916C (no)
AR (1) AR035807A1 (no)
BG (1) BG108235A (no)
BR (1) BR0208830A (no)
CA (1) CA2443464A1 (no)
CZ (1) CZ20032759A3 (no)
EE (1) EE200300506A (no)
HU (1) HUP0303481A3 (no)
IL (1) IL158035A0 (no)
IS (1) IS6990A (no)
MX (1) MXPA03009213A (no)
MY (1) MY141595A (no)
NO (1) NO20034528L (no)
NZ (1) NZ528559A (no)
PL (1) PL367182A1 (no)
RU (1) RU2003129229A (no)
SK (1) SK12542003A3 (no)
TW (1) TWI259836B (no)
WO (1) WO2002083687A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US20080262444A1 (en) 2005-01-31 2008-10-23 Bioserentach Co., Ltd. Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment
AR057064A1 (es) 2005-06-13 2007-11-14 Astrazeneca Ab Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto
TW200940110A (en) * 2008-02-22 2009-10-01 Astrazeneca Ab Pharmaceutical formulation comprising oxabispidines
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
BR0009651A (pt) * 1999-04-09 2002-01-08 Astrazeneca Ab Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
SE0101329D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Pharmaceutical formulation

Also Published As

Publication number Publication date
CA2443464A1 (en) 2002-10-24
HUP0303481A2 (hu) 2004-01-28
EE200300506A (et) 2004-02-16
RU2003129229A (ru) 2005-04-10
EP1389211A1 (en) 2004-02-18
TWI259836B (en) 2006-08-11
MXPA03009213A (es) 2004-01-29
HUP0303481A3 (en) 2005-04-28
JP2004525969A (ja) 2004-08-26
US20040132798A1 (en) 2004-07-08
BR0208830A (pt) 2004-03-09
WO2002083687A1 (en) 2002-10-24
BG108235A (bg) 2005-04-30
NZ528559A (en) 2005-03-24
IS6990A (is) 2003-10-10
IL158035A0 (en) 2004-03-28
PL367182A1 (en) 2005-02-21
SK12542003A3 (sk) 2004-03-02
KR20040005917A (ko) 2004-01-16
CN1514838A (zh) 2004-07-21
NO20034528L (no) 2003-12-08
CN1279916C (zh) 2006-10-18
MY141595A (en) 2010-05-14
AR035807A1 (es) 2004-07-14
CZ20032759A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20026030L (no) Pyrrolo[2,3-d]pyramidin-forbindelser som immunosuppresive midler
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20034527D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
ATE209899T1 (de) Feste, schnellzerfallende cetirizin- formulierungen
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
DK1429607T3 (da) Delta-1-pyrroliner som pesticider
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
DK1263734T3 (da) 3-thiomethylpyrazoler som pesticider
NO20034529L (no) 3,7-diazabicyklo(3,3,1) - formuleringer som anti-arytmi- forbindelser
NO20034528L (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
DK1322608T3 (da) Delta1-Pyrroliner som pesticider
DK1497256T3 (da) Substituerede 1,5-diaminopentan-3-ol-forbindelser
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
DK1453820T3 (da) Substituerede 6H-dibenzo{c,h]vhromener som östrogene midler
TH85054EX (th) ???????????????????????????????????????????????
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
DK1448553T3 (da) N-Heterocyclylhydrazider som neurotrofe midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application